Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Expert video report on carcinoid syndrome

Juan Valle explains that some patients with neuroendocrine tumours suffer from carcinoid syndrome characterised by very specific symptoms. He stressed out why it is important to detect it, and details its physiopathology, how carcinoid syndrome should be managed and what are the available treatments.

Reprinted from:
Mamikunian G, et al, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management. (4th ed.) Inglewood, CA: Inter Science Institute; 2009, with permission from InterScience Institute.
Daniel M Halperin et al., Lancet Oncol., Vol. 18(4), Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study, Pages 525-534, Copyright (2017), with permission from Elsevier.
Pavel M, et al., Neuroendocrinology, Vol. 103(2), ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site, Pages 172-85, Copyright (2016), with permission from Karger.
Jensen R. In: Harrison’s Principles of Internal Medicine Online. (17th ed) New York, NY: McGraw-Hill, Inc; Copyright (2008), with permission from McGraw-Hill Education.

This video was supported with an unrestricted grant from IPSEN. The selection of questions covered in this track is exclusively under the responsibility of ESMO and the speakers selected by ESMO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings